Recombinant SARS-CoV-2 Spike antibody (B.1.351 – beta)

Catalog No. ABIN7515621

Product Details anti-SARS-CoV-2 Spike Antibody

Target: SARS-CoV-2 Spike

Antibody Type: Recombinant Antibody

Binding Specificity: B.1.351 – beta

Reactivity: SARS Coronavirus-2 (SARS-CoV-2), SARS CoV-2 Beta

Host: Human

Clonality: Monoclonal

Conjugate: This SARS-CoV-2 Spike antibody is un-conjugated

Application: ELISA, Neutralization (Neut)

Purpose: Recombinant human monoclonal antibody raised against SARS-CoV-2 Beta Variant S.

Specificity: Reacts with RBD domain of spike protein of SARS-CoV-2, including South Africa variant (B.1.351) and UK variant (B.1.1.7).

Cross-Reactivity: SARS Coronavirus-2 (SARS-CoV-2)

Immunogen: Recombinant protein corresponding to SARS-CoV-2 Variant B.1.351 S.

Isotype: IgG

Application Details

Application Notes: ELISA,Neutralization Assay,The optimal working dilution should be determined by the end user.

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: In PBS (40 % glycerol).

Storage: 4 °C,-20 °C

Storage Comment: Store at 4°C is stable for 6 months from the date of shipment. For long term storage, store at -20°C.
Aliquot to avoid repeated freezing and thawing.

Target Details for SARS-CoV-2 Spike

Target: SARS-CoV-2 Spike

Abstract: SARS-CoV-2 Spike Products

Synonyms: E2 antibody, E2 glycoprotein precursor antibody, Surface Glycoprotein antibody, S antibody

Target Type: Viral Protein